These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 32316547)
1. Macrophage Phenotype and Fibrosis in Diabetic Nephropathy. Calle P; Hotter G Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316547 [TBL] [Abstract][Full Text] [Related]
2. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy. Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947 [TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy. Yuan Y; Li L; Zhu L; Liu F; Tang X; Liao G; Liu J; Cheng J; Chen Y; Lu Y Stem Cells; 2020 May; 38(5):639-652. PubMed ID: 31904160 [TBL] [Abstract][Full Text] [Related]
4. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model. Yu J; Dong R; Da J; Li J; Yu F; Zha Y Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283 [TBL] [Abstract][Full Text] [Related]
5. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042 [TBL] [Abstract][Full Text] [Related]
6. Intraglomerular Monocyte/Macrophage Infiltration and Macrophage-Myofibroblast Transition during Diabetic Nephropathy Is Regulated by the A Torres Á; Muñoz K; Nahuelpán Y; R Saez AP; Mendoza P; Jara C; Cappelli C; Suarez R; Oyarzún C; Quezada C; San Martín R Cells; 2020 Apr; 9(4):. PubMed ID: 32340145 [TBL] [Abstract][Full Text] [Related]
7. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy. Zeng LF; Xiao Y; Sun L Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961 [TBL] [Abstract][Full Text] [Related]
8. Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy. Wang X; Yao B; Wang Y; Fan X; Wang S; Niu A; Yang H; Fogo A; Zhang MZ; Harris RC Diabetes; 2017 Feb; 66(2):494-504. PubMed ID: 27815317 [TBL] [Abstract][Full Text] [Related]
9. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway. Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474 [TBL] [Abstract][Full Text] [Related]
10. Mitophagy regulates macrophage phenotype in diabetic nephropathy rats. Zhao Y; Guo Y; Jiang Y; Zhu X; Liu Y; Zhang X Biochem Biophys Res Commun; 2017 Dec; 494(1-2):42-50. PubMed ID: 29061302 [TBL] [Abstract][Full Text] [Related]
11. Macrophage accumulation in human progressive diabetic nephropathy. Nguyen D; Ping F; Mu W; Hill P; Atkins RC; Chadban SJ Nephrology (Carlton); 2006 Jun; 11(3):226-31. PubMed ID: 16756636 [TBL] [Abstract][Full Text] [Related]
12. Excessive Activation of Notch Signaling in Macrophages Promote Kidney Inflammation, Fibrosis, and Necroptosis. Ma T; Li X; Zhu Y; Yu S; Liu T; Zhang X; Chen D; Du S; Chen T; Chen S; Xu Y; Fan Q Front Immunol; 2022; 13():835879. PubMed ID: 35280997 [TBL] [Abstract][Full Text] [Related]
13. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment. Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379 [TBL] [Abstract][Full Text] [Related]
14. Macrophages in diabetic nephropathy in patients with type 2 diabetes. Klessens CQF; Zandbergen M; Wolterbeek R; Bruijn JA; Rabelink TJ; Bajema IM; IJpelaar DHT Nephrol Dial Transplant; 2017 Aug; 32(8):1322-1329. PubMed ID: 27416772 [TBL] [Abstract][Full Text] [Related]
15. Relationship between Macrophages and Tissue Microenvironments in Diabetic Kidneys. Yan J; Li X; Liu N; He JC; Zhong Y Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509528 [TBL] [Abstract][Full Text] [Related]
16. A2BAR Antagonism Decreases the Glomerular Expression and Secretion of Chemoattractants for Monocytes and the Pro-Fibrotic M2 Macrophages Polarization during Diabetic Nephropathy. Torres-Arévalo Á; Nahuelpán Y; Muñoz K; Jara C; Cappelli C; Taracha-Wiśniewska A; Quezada-Monrás C; Martín RS Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446007 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Monocytes/Macrophages by the Renin-Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study. Moratal C; Laurain A; Naïmi M; Florin T; Esnault V; Neels JG; Chevalier N; Chinetti G; Favre G Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199409 [TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy. Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG Nephron; 2015; 129(2):109-27. PubMed ID: 25662516 [TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy, inflammation, hyaluronan and interstitial fibrosis. Lewis A; Steadman R; Manley P; Craig K; de la Motte C; Hascall V; Phillips AO Histol Histopathol; 2008 Jun; 23(6):731-9. PubMed ID: 18366011 [TBL] [Abstract][Full Text] [Related]
20. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy. Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]